NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ArcticZymes Technologies ASA (OL: AZT)

 
AZT Technical Analysis
4
As on 28th Nov 2025 AZT STOCK Price closed @ 22.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 19.19 & Strong Buy for SHORT-TERM with Stoploss of 14.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AZTSTOCK Price

Open 22.60 Change Price %
High 22.90 1 Day 0.00 0.00
Low 22.50 1 Week 0.90 4.15
Close 22.60 1 Month -6.40 -22.07
Volume 18405 1 Year 9.60 73.85
52 Week High 30.90 | 52 Week Low 12.74
 
OL Norway Most Active Stocks
AGAS 0.24 71.43%
PLT 6.86 -16.24%
TRE 39.50 11.90%
BORR 40.56 0.00%
HUNT 2.35 7.31%
AOW 2.00 -5.21%
ARR 7.18 2.57%
KOA 1.84 2.79%
NAS 17.30 1.53%
MPCC 17.92 1.82%
 
OL Norway Top Gainers Stocks
AGAS 0.24 71.43%
CONTX 4.17 16.16%
HBC 1.60 12.68%
HBC 1.60 12.68%
HBC 1.60 12.68%
INSR 0.18 12.50%
TRE 39.50 11.90%
TRE 39.50 11.90%
TRE 39.50 11.90%
KOMP 5.22 9.66%
 
OL Norway Top Losers Stocks
PLT 6.86 -16.24%
PLT 6.86 -16.24%
PLT 6.86 -16.24%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
NODL 0.23 -11.54%
 
 
AZT
Daily Charts
AZT
Intraday Charts
Whats New @
Bazaartrend
AZT
Free Analysis
 
AZT Important Levels Intraday
RESISTANCE23.37
RESISTANCE23.12
RESISTANCE22.97
RESISTANCE22.82
SUPPORT22.38
SUPPORT22.23
SUPPORT22.08
SUPPORT21.83
 
AZT Forecast November 2025
4th UP Forecast37.44
3rd UP Forecast32.68
2nd UP Forecast29.74
1st UP Forecast26.8
1st DOWN Forecast18.4
2nd DOWN Forecast15.46
3rd DOWN Forecast12.52
4th DOWN Forecast7.76
 
AZT Weekly Forecast
4th UP Forecast24.41
3rd UP Forecast23.83
2nd UP Forecast23.47
1st UP Forecast23.11
1st DOWN Forecast22.09
2nd DOWN Forecast21.73
3rd DOWN Forecast21.37
4th DOWN Forecast20.79
 
AZT Forecast2025
4th UP Forecast59.33
3rd UP Forecast47.55
2nd UP Forecast40.27
1st UP Forecast32.99
1st DOWN Forecast12.21
2nd DOWN Forecast4.93
3rd DOWN Forecast-2.35
4th DOWN Forecast-14.13
 
 
AZT Other Details
Segment EQ
Market Capital 4083952128.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
AZT Address
AZT
 
AZT Latest News
 
Your Comments and Response on ArcticZymes Technologies ASA
 
AZT Business Profile
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and markets recombinant enzymes derived from cold-water marine species and organisms from other relevant environments for use in molecular research, in vitro diagnostics (IVD), and therapeutics in Norway, Europe, Asia, Australia, Africa, and the Americas. It offers shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing (NGS) processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; salt active nuclease for the removal of nucleic acids during manufacturing of vaccines, viruses, recombinant proteins, and other reagents; and ligases for joining DNA fragments. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway. Address: Sykehusveien 23, Tromsø, Norway, 9294
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service